Biopharmaceutical Compositions
Patent No. EP4056590 (titled "Biopharmaceutical Compositions") was filed by Glaxosmithkline on Aug 22, 2016. The application was issued on Oct 15, 2025.
Patent Summary
Patent Family
Statuses, jurisdictions and citation links are shared on request.
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
EP4056590
- Application Number
- EP22152628A
- Filing Date
- Aug 22, 2016
- Status
- Granted And Under Opposition
- Sep 12, 2025
- Publication Date
- Oct 15, 2025
- External Links
- Slate, Register , Google Patents